Related Experiment Video
Updated: Jun 2, 2026
06:48
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Metabolic imbalance and prostate cancer progression
Summary
Western lifestyle factors like obesity and insulin resistance are linked to prostate cancer development. Lifestyle interventions may help reduce prostate cancer incidence, but more research is needed.
Area of Science:
- Oncology
- Metabolic Syndrome
- Environmental Health
Background:
- Environmental factors significantly influence prostate cancer progression.
- Western lifestyle-associated metabolic changes (obesity, insulin resistance) are implicated in prostate carcinogenesis.
- Obesity, insulin resistance, and inflammation are linked to prostate cancer through various pathways.
Purpose of the Study:
- To review the evidence linking metabolic consequences of Western lifestyle to prostate cancer.
- To explore the roles of insulin, IGF-1, adipokines, sex hormones, and inflammation in prostate carcinogenesis.
- To identify potential therapeutic targets and the role of lifestyle interventions.
Main Methods:
- Review of existing scientific literature and evidence.
- Analysis of molecular and cellular mechanisms.
- Examination of observational and population-level studies.
Main Results:
- Insulin resistance elevates mitogens like insulin and IGF-1, potentially promoting prostate cancer.
- Obesity is associated with altered adipokines, sex hormones, and inflammatory cytokines affecting prostate cancer.
- Prostatic inflammation and high dietary ω-6 fatty acids may drive cancer progression.
- Altered fatty acid and amino acid metabolism are observed in prostate cancer tissue.
Conclusions:
- Metabolic dysregulation driven by lifestyle is a key factor in prostate cancer.
- Potential exists for lifestyle interventions to reduce prostate cancer incidence.
- Further research is essential to establish definitive recommendations for lifestyle modifications.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:19Psychoneuroimmunology: Diabetes and Cancer
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
01:21Overview of Protein Metabolism
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...